M Bentz

Author PubWeight™ 74.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000 16.30
2 p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995 4.12
3 IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999 2.58
4 Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A 2000 2.22
5 Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 2000 2.09
6 Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996 1.85
7 Quantitative analysis of comparative genomic hybridization. Cytometry 1995 1.72
8 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997 1.69
9 Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996 1.63
10 Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer 1999 1.39
11 Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med (Berl) 1999 1.21
12 Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg 2001 1.12
13 Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals. Genes Chromosomes Cancer 1999 1.11
14 Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995 1.11
15 Comparative genomic hybridization: uses and limitations. Semin Hematol 2000 1.11
16 Renal cell carcinoma metastatic to the scalp: case report and review of the literature. Dermatol Surg 2001 1.06
17 Image analysis in comparative genomic hybridization. Cytometry 1995 1.05
18 Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A 1996 1.00
19 Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 1999 1.00
20 High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis. Leukemia 2003 0.99
21 Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int J Cancer 2001 0.99
22 Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998 0.96
23 High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol 1997 0.96
24 Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol 1995 0.95
25 Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 1997 0.95
26 Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001 0.94
27 Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Leukemia 2007 0.92
28 Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999 0.91
29 Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 1997 0.91
30 Subtotal maxillectomy for melanotic neuroectodermal tumor of infancy. Plast Reconstr Surg 1999 0.90
31 Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann Hematol 1998 0.88
32 Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 1996 0.88
33 Ultra-sensitive FISH is a useful tool for studying chronic HIV-1 infection. J Virol Methods 1997 0.87
34 Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996 0.86
35 DNA microarray analysis in malignant lymphomas. Ann Hematol 2003 0.85
36 Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens. Ann Oncol 2008 0.84
37 Comparative clinical study of the sure-closure device with conventional wound closure techniques. Ann Plast Surg 1995 0.84
38 Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Ann Oncol 2007 0.84
39 The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol 2000 0.83
40 Trisomy 12 in chronic lymphoid leukemias--a metaphase and interphase cytogenetic analysis. Leukemia 1993 0.83
41 Multiple antibody response in Schistosoma mansoni infections: antigenic constituents in eggs, cercariae, and adults (excretions and secretions) determined by flocculation reactions, cross absorption and double diffusion studies. Am J Trop Med Hyg 1965 0.82
42 [Precipitating antibodies present in the blood and cerebrospinal fluid of patients with human African trypanosomiasis due to T. gambiense]. Ann Inst Pasteur (Paris) 1967 0.82
43 Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa. Dermatol Surg 2001 0.82
44 Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules. Virchows Arch 2000 0.82
45 High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993 0.81
46 Risk of false positive results in comparative genomic hybridization. Genes Chromosomes Cancer 2000 0.81
47 Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells. Infect Immun 2003 0.80
48 Examination of the roles of glycoprotein Ib and glycoprotein IIb/IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade. Blood 1991 0.78
49 Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 1995 0.78
50 Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis. Leukemia 2001 0.78
51 Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization. Stem Cells 1995 0.77
52 Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias. Leuk Lymphoma 1994 0.77
53 Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens. Cytokines Mol Ther 1996 0.77
54 Chromosomal aberrations in lymphomas of the gastrointestinal tract. Leuk Lymphoma 1999 0.76
55 BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma. Leukemia 2000 0.76
56 Comparative genomic hybridization for the analysis of leukemias and lymphomas. Methods Mol Med 2001 0.75
57 [A new dimension of DNA analysis: genomic profiling by matrix CGH]. Verh Dtsch Ges Pathol 2003 0.75
58 Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas. Ann Hematol 2001 0.75
59 [Fluorescence in-situ hybridization (FISH). Method and application]. Med Klin (Munich) 1997 0.75
60 Venous gangrene of the upper extremity. Ann Plast Surg 1998 0.75
61 CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia. Br J Haematol 1995 0.75
62 High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genet Cytogenet 1996 0.75
63 Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis. Ann Neurol 2000 0.75
64 Molecular cytogenetic analysis of low-grade B-cell neoplasias: a comparative genomic hybridization study. Recent Results Cancer Res 1998 0.75
65 Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. Am J Hematol 2012 0.75
66 Molecular aspects of B-cell lymphomas of the gastrointestinal tract. Clin Lymphoma 2001 0.75
67 [Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging]. Rofo 1993 0.75